Hamblin, Lavery Join Hologenix Board

Based in Santa Monica, Calif., Hologenix LLC, maker of Celliant technology, has completed its science advisory board with the appointments of Drs. Michael R. Hamblin and Lawrence A. Lavery. It also has established a research and development laboratory. With more than 30 years of experience, Hamblin is the principal investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital in Cambridge and an associate professor of dermatology at Harvard Medical School. He is also a member of the affiliated faculty of the Harvard-MIT Div. of Health Science and Technology. Lavery is a professor of surgery at the University of Texas Southwestern Medical Center.